# ApiJect awarded $138M DPA contract for syringe production

ApiJect Systems America was awarded a $138 million HHS-DOD Title 3 Defense Production Act contract to accelerate building U.S.-based capacity for prefilled syringes, including Project Jumpstart to supply 100 million syringes by end of 2020 and over 500 million in 2021.

- Type: Contract
- Announced: 2020-05-12
- Where: Stamford, Connecticut, United States
- Value: $138.0M
- Jobs: 500
- Status: announced
- Capacity: 30 million prefilled syringes per month initially; 330 million per month at full capacity
- Products: prefilled syringes, needle hubs
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [ApiJect Systems America, Inc.](https://endata.com/companies/47191.md)
- [RAPID USA Inc.](https://endata.com/companies/47192.md) (partner)

## Sources

- [prnewswire.com](https://www.prnewswire.com/news-releases/apiject-awarded-hhs-dod-title-3-defense-production-act-dpa-contract-of-138-million-in-support-of-a-joint-federal-agency-accelerated-build-out-of-domestic-surge-capacity-for-a-high-speed-population-scale-emergency-drug-injecti-301058125.html), 2020-05-12: "ApiJect Systems America, Inc., a public benefit corporation based here, today announced that it has been awarded an HHS-DOD Title 3, DPA contract valued up to $138 million to accelerate the building of a new U.S.-based, high-speed, population-scale emergency drug injection capability with prefilled "

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.